{"title":"New antidepressants: monoamines and beyond","authors":"M. Greener","doi":"10.1002/psb.2032","DOIUrl":null,"url":null,"abstract":"The monoamine hypothesis of depression has dominated treatment for decades, but for some with treatment‐resistant depression, alternative approaches are needed. This article discusses some of the other mechanisms involved in depression and how novel treatments could address these.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"56 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The monoamine hypothesis of depression has dominated treatment for decades, but for some with treatment‐resistant depression, alternative approaches are needed. This article discusses some of the other mechanisms involved in depression and how novel treatments could address these.